Navigation Links
CELLING Treatment Centers New Clinic Revolutionizes Spinal Care with Adult Stem Cells
Date:7/7/2010

Now open in Austin, Texas, CELLING patients can seek out cutting-edge stem cell treatments designed to enhance their quality of life.

Austin, TX (Vocus) July 7, 2010 -- The future of medicine has arrived in Texas -- CELLING Treatment Center is newly open in Austin, providing stem cell therapies for common back and spine disorders. Minimally invasive but maximally effective, Celling Treatment Center techniques promise to set the new standard for spinal and orthopedic surgery.

Dr. Mark A. Flood, chief surgeon and medical director of the center, said, “Stem cell science has now advanced to the point where clinical applications in orthopedic and spinal surgery are now a reality.”

CELLING Treatment Centers is poised to become patient’s first choice for non-fusion strategies to treat spinal disorders and the orthopedic applications of stem cells in conditions of aging and injury. Patients can access a wide array of top quality conventional and novel treatments for back problems, joint problems, sports injuries and more. And while conventional fusion approaches can often result in painful failure, minimally invasive approaches are much more promising for both fixing the back and for avoiding post-surgical complications.

Dr. Flood is a pioneer in the use of stem cells in concert with minimally invasive approaches to orthopedic surgery on the spine and extremities. Board certified, Dr. Flood brings an extensive background in minimally invasive spine surgery methods, such as endoscopic and laser spine surgery. He is fellowship trained in both adult and pediatric spinal surgery.

Stem cells differ from ordinary cells in some significant ways. They have the unique abilities to self-renew and to divide for a long period. Under certain conditions, stem cells can be induced to differentiate into specialized cells with distinct functions including, but not limited to, cardiac cells, liver cells, fat cells, bone cells, cartilage cells, nerve cells, and connective tissue cells. As medical science develops a more precise understanding of the pure potential locked inside stem cells, clinicians like Dr. Flood can create exiting new more effective, treatments for disease, degeneration or injury.

“Dr. Mark Flood has exhibited a career long interest in adopting innovative therapies in pursuit of the best possible outcomes for his patients. He has extensive experience in minimally invasive surgical procedures and a long term interest in stem cells and cell based therapies which make him an ideal physician to partner with for the advancement of cell based therapies.” said Kevin Dunworth, Founder & CEO of Celling Technologies.

The group behind CELLING Treatment Centers sees the great potential for stem cell based treatments. They have ambitious plans to open the first surgical center and lab in the United States dedicated to the clinical application of non-embryonic stem cells across multiple medical specialties. A second site in the United States has been selected. Additional sites in Europe and the UAE are being evaluated.

###

Read the full story at http://www.prweb.com/releases/2010/07/prweb4153014.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Patients with treatment-resistant CLL respond positively to stem cell transplants
2. Study Seeks Effective Treatment for Adolescent Low Back Pain
3. Experimental nonsteroidal treatment of asthma shows promise
4. Allegheny Medical's SportsCare Programs Combine Lifestyle, Fitness and Behavior Management with Quality Medical Treatments
5. University at Buffalo launches clinical trial of new multiple sclerosis treatment
6. New non-surgical treatment for uterine fibroids can improve quality of life
7. Alternative Menopause Treatments, Discussed by Dr. Ershadi
8. Surprising find may yield new avenue of treatment for painful herniated discs
9. Clinical Trial Testing New Multiple Sclerosis Treatment to Launch in Buffalo
10. Bursting bubbles with sound offers new treatments for cancer
11. Allergy Treatments and Symptoms Website Ready to Help
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet ... product that was developed to enhance the health of felines. The formula is all-natural ... two main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: